AU8038491A - Purine derivatives - Google Patents
Purine derivativesInfo
- Publication number
- AU8038491A AU8038491A AU80384/91A AU8038491A AU8038491A AU 8038491 A AU8038491 A AU 8038491A AU 80384/91 A AU80384/91 A AU 80384/91A AU 8038491 A AU8038491 A AU 8038491A AU 8038491 A AU8038491 A AU 8038491A
- Authority
- AU
- Australia
- Prior art keywords
- purine derivatives
- purine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH238790 | 1990-07-18 | ||
| CH2387/90 | 1990-07-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8038491A true AU8038491A (en) | 1992-01-23 |
Family
ID=4232597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU80384/91A Abandoned AU8038491A (en) | 1990-07-18 | 1991-07-11 | Purine derivatives |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0467207A3 (en) |
| JP (1) | JPH04234391A (en) |
| KR (1) | KR920002600A (en) |
| AU (1) | AU8038491A (en) |
| CA (1) | CA2044806A1 (en) |
| FI (1) | FI913407A (en) |
| HU (1) | HU209591B (en) |
| IE (1) | IE912500A1 (en) |
| IL (1) | IL98812A0 (en) |
| MC (1) | MC2278A1 (en) |
| NO (1) | NO912804L (en) |
| PT (1) | PT98348A (en) |
| ZA (1) | ZA915418B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE70593B1 (en) * | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
| US5202328A (en) * | 1991-03-06 | 1993-04-13 | Merck & Co., Inc. | Substituted fused pyrimidinones |
| TW274551B (en) * | 1991-04-16 | 1996-04-21 | Takeda Pharm Industry Co Ltd | |
| SE9903028D0 (en) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| PE20030008A1 (en) | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | DUAL INHIBITORS OF PDE 7 AND PDE 4 |
| EP2527360B1 (en) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US8034782B2 (en) | 2008-07-16 | 2011-10-11 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EA201592263A1 (en) | 2013-06-05 | 2016-05-31 | Синерджи Фармасьютикалз, Инк. | ULTRASCULAR AGONISTS OF GUANYLACYCLASE C, METHOD OF THEIR RECEIVING AND USING |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
| IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them |
| IL96019A0 (en) * | 1989-10-31 | 1991-07-18 | Fujisawa Pharmaceutical Co | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| EP0430300A3 (en) * | 1989-12-01 | 1992-03-25 | Takeda Chemical Industries, Ltd. | Xanthine derivatives, their production and use |
-
1991
- 1991-06-17 CA CA002044806A patent/CA2044806A1/en not_active Abandoned
- 1991-07-10 EP EP19910111468 patent/EP0467207A3/en not_active Withdrawn
- 1991-07-11 MC MC912204A patent/MC2278A1/en unknown
- 1991-07-11 ZA ZA915418A patent/ZA915418B/en unknown
- 1991-07-11 AU AU80384/91A patent/AU8038491A/en not_active Abandoned
- 1991-07-12 IL IL98812A patent/IL98812A0/en unknown
- 1991-07-12 HU HU912347A patent/HU209591B/en not_active IP Right Cessation
- 1991-07-15 FI FI913407A patent/FI913407A/en not_active Application Discontinuation
- 1991-07-15 JP JP3198267A patent/JPH04234391A/en active Pending
- 1991-07-16 KR KR1019910012146A patent/KR920002600A/en not_active Application Discontinuation
- 1991-07-17 NO NO91912804A patent/NO912804L/en unknown
- 1991-07-17 IE IE250091A patent/IE912500A1/en unknown
- 1991-07-17 PT PT98348A patent/PT98348A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO912804D0 (en) | 1991-07-17 |
| KR920002600A (en) | 1992-02-28 |
| MC2278A1 (en) | 1993-06-23 |
| HUT58736A (en) | 1992-03-30 |
| IE912500A1 (en) | 1992-01-29 |
| FI913407A0 (en) | 1991-07-15 |
| PT98348A (en) | 1992-05-29 |
| IL98812A0 (en) | 1992-07-15 |
| HU912347D0 (en) | 1991-12-30 |
| FI913407A (en) | 1992-01-19 |
| EP0467207A2 (en) | 1992-01-22 |
| NO912804L (en) | 1992-01-20 |
| ZA915418B (en) | 1992-03-25 |
| EP0467207A3 (en) | 1992-08-12 |
| JPH04234391A (en) | 1992-08-24 |
| CA2044806A1 (en) | 1992-01-19 |
| HU209591B (en) | 1994-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU653734B2 (en) | Substituted 4-biphenylmethoxypyridine derivatives | |
| AU644249B2 (en) | Alpha-oxoacetamide derivatives | |
| AU638496B2 (en) | Acyl-biphenylyl-alkyl pyrimidine derivatives | |
| AU7392191A (en) | Thienopyrimidine derivatives | |
| AU4764990A (en) | 3-Aryl-4-hydroxy-delta3-pyrroline-2-one derivatives | |
| AU7707591A (en) | Hydroquinazoline derivatives | |
| AU7500891A (en) | Benzimidazolinone derivatives | |
| AU5892490A (en) | Thienodiazepine derivatives | |
| AU1655192A (en) | Antivizal dibenzothiazepinone derivatives | |
| AU6860691A (en) | Azaoxindole derivatives | |
| AU646273B2 (en) | Acetamide derivatives | |
| AU8612491A (en) | Antiviral compounds | |
| AU8033891A (en) | Pyrimidine derivatives | |
| AU5641590A (en) | 3-arylurail derivatives | |
| AU8038491A (en) | Purine derivatives | |
| AU7825291A (en) | Pyridinypiperazine derivatives | |
| PL309610A1 (en) | Purine derivatives | |
| AU2416088A (en) | Purine derivatives | |
| AU6204690A (en) | Epiopodophyllotoxin altroside derivatives | |
| AU1033992A (en) | 3-quinuclidine derivatives | |
| AU638840B2 (en) | Pyrimidine derivative | |
| AU8334691A (en) | Antiviral agent | |
| AU3719489A (en) | Purine derivatives | |
| AU7507591A (en) | Antiviral compounds | |
| AU3607189A (en) | Pyrimidine derivatives |